SPBC1711.03 Antibody

What is SPBC1711.03 and why is it important in fission yeast research?

SPBC1711.03 (also known as aim27) is a gene in Schizosaccharomyces pombe (strain 972 / ATCC 24843), commonly known as fission yeast. This gene encodes a protein with the UniProt accession number Q9P787 . While specific functional studies on SPBC1711.03 are ongoing, research into fission yeast genes provides valuable insights into fundamental cellular processes. Fission yeast serves as an excellent model organism due to its relatively simple genome and cellular organization, while maintaining many conserved pathways relevant to higher eukaryotes.

The study of SPBC1711.03 antibody allows researchers to investigate gene expression patterns, protein localization, and functional responses, particularly in the context of environmental stress responses that have been extensively documented in S. pombe .

What applications is the SPBC1711.03 antibody suitable for?

The commercially available SPBC1711.03 antibody has been validated for the following applications:

The antibody is supplied as a package containing :

• 200μg recombinant immunogen (positive control)

• 1ml pre-immune serum (negative control)

• Rabbit polyclonal antibodies purified by Antigen Affinity

This antibody is specifically developed against recombinant Schizosaccharomyces pombe (strain 972 / ATCC 24843) SPBC1711.03 protein, making it an isotype IgG polyclonal antibody derived from rabbit .

What are the optimal storage conditions for SPBC1711.03 antibody?

For maximum stability and activity retention, SPBC1711.03 antibody should be stored at either -20°C or -80°C . When handling the antibody:

• Avoid repeated freeze-thaw cycles by aliquoting the antibody upon first thaw

• When shipping is required, use blue ice packaging to maintain cold chain integrity

• Allow the antibody to equilibrate to room temperature before opening the tube

• Briefly centrifuge before use to collect all material at the bottom of the tube

• Working dilutions should be prepared fresh before use and stored at 4°C for short-term use (1-2 days)

Long-term storage stability can significantly impact experimental reproducibility, especially in time-course studies spanning several months.

How should I design controls when using SPBC1711.03 antibody in my experiments?

Proper experimental controls are critical for interpreting results with SPBC1711.03 antibody. A comprehensive control strategy should include:

Positive Controls:

• Use the supplied 200μg recombinant immunogen protein as a positive control

• Include wild-type strain 972 h- samples as reference material

Negative Controls:

• Use the supplied pre-immune serum as a primary antibody negative control

• Include samples from SPBC1711.03 deletion mutants if available

• For stress response studies, include unstressed control samples

Specificity Controls:

• Perform peptide competition assays to confirm antibody specificity

• Include cross-reactivity tests with closely related proteins

• If studying stress responses, include parallel analyses of known stress-response genes like those dependent on Sty1p and Atf1p transcription factors

This control framework enables reliable data interpretation by distinguishing specific signals from background or non-specific binding.

What is the optimal protocol for Western blotting using SPBC1711.03 antibody?

For optimal Western blot results with SPBC1711.03 antibody, consider the following methodological approach:

• Sample preparation:

  • Extract proteins from S. pombe cells using either glass bead lysis in the presence of protease inhibitors or TCA precipitation

  • Include both soluble and membrane fractions to ensure complete protein extraction

  • Quantify protein concentration using Bradford or BCA assay

• Gel electrophoresis:

  • Use 10-12% SDS-PAGE gels for optimal separation

  • Load 20-50μg of total protein per lane

  • Include molecular weight markers spanning the expected protein size range

• Antibody incubation:

  • Block membrane with 5% non-fat milk in TBST for 1 hour at room temperature

  • Incubate with SPBC1711.03 antibody at 1:500-1:2000 dilution in TBST with 1% BSA overnight at 4°C

  • Wash 3×10 minutes with TBST

  • Incubate with HRP-conjugated anti-rabbit secondary antibody (1:5000-1:10000) for 1 hour at room temperature

• Detection:

  • Develop using enhanced chemiluminescence (ECL) substrate

  • Expose to X-ray film or use digital imaging system

  • For quantitative analysis, ensure exposure is in the linear range

This protocol is based on general practices for fission yeast protein detection and should be optimized for the specific experimental conditions.

How can SPBC1711.03 antibody be used in studying stress response pathways in fission yeast?

SPBC1711.03 antibody can be valuable for investigating stress response pathways in S. pombe through these methodological approaches:

• Time-course experiments:

  • Subject cells to different stresses (oxidative, osmotic, heat shock, heavy metal, DNA damage) using established protocols

  • Collect samples at multiple timepoints (0, 15, 60 minutes) after stress induction

  • Analyze protein expression changes using Western blotting with SPBC1711.03 antibody

  • Compare with transcriptional changes using parallel RNA extraction and RT-qPCR

• Integration with known stress pathways:

  • Compare protein expression patterns in wild-type versus stress-response mutants (e.g., Δsty1, Δatf1)

  • Assess whether SPBC1711.03 is part of the core environmental stress response (CESR) or specific stress pathways

  • Investigate potential co-regulation with known stress-responsive genes

• Quantitative analysis:

  • Measure relative protein abundance across conditions using densitometry of Western blots

  • Correlate protein levels with transcriptional changes and physiological responses

This approach can help position SPBC1711.03 within the well-characterized stress response network of fission yeast, providing insights into its functional role.

How can bioinformatic approaches complement experimental studies with SPBC1711.03 antibody?

Integrating bioinformatic analyses with SPBC1711.03 antibody experiments creates a more comprehensive research framework:

• Sequence analysis and homology:

  • Identify conserved domains in SPBC1711.03 protein sequence

  • Compare with homologs in other species to infer potential functions

  • Analyze promoter regions for transcription factor binding sites related to stress response elements

• Integration with existing datasets:

  • Compare with stress response transcriptome data in S. pombe

  • Identify potential protein interaction partners from databases

  • Analyze correlation patterns in expression with known genes

• Structural prediction:

  • Use tools like RFdiffusion or RoseTTAFold2 to predict protein structure

  • Identify potential binding sites or functional domains

  • Guide antibody epitope mapping experiments

This computational framework can generate testable hypotheses and provide context for interpreting experimental results with SPBC1711.03 antibody.

What considerations are important when using SPBC1711.03 antibody for studying protein-protein interactions?

When investigating protein-protein interactions involving SPBC1711.03, consider these methodological factors:

• Co-immunoprecipitation (Co-IP) approach:

  • Use SPBC1711.03 antibody for direct pull-down experiments

  • Optimize lysis conditions to preserve native protein complexes

  • Include crosslinking steps for transient interactions

  • Confirm interactions with reciprocal Co-IPs using antibodies against potential interacting partners

• Validation strategies:

  • Confirm interactions using multiple techniques (e.g., yeast two-hybrid, proximity ligation assay)

  • Include appropriate controls for non-specific binding

  • Consider size exclusion chromatography to isolate native complexes

• Functional confirmation:

  • Assess the effect of environmental stresses on observed interactions

  • Analyze interactions in relevant mutant backgrounds

  • Correlate interaction data with functional assays

This multifaceted approach can establish the biological relevance of identified interactions and their role in stress response or other cellular pathways.

How can SPBC1711.03 antibody contribute to understanding post-translational modifications in response to stress?

Investigating post-translational modifications (PTMs) of SPBC1711.03 protein requires specialized approaches:

• Detection methodology:

  • Use phospho-specific Western blotting by combining SPBC1711.03 antibody with phosphorylation state-specific detection methods

  • Employ Phos-tag gels to separate phosphorylated from non-phosphorylated forms

  • Combine immunoprecipitation with mass spectrometry to identify specific modification sites

• Experimental design:

  • Compare PTM patterns across different stress conditions and timepoints

  • Analyze PTMs in kinase or phosphatase mutant backgrounds to identify regulatory enzymes

  • Correlate modifications with protein activity or localization changes

• Functional significance:

  • Generate phospho-mimetic or phospho-dead mutants of key residues

  • Assess the impact of mutations on protein function and stress response

  • Investigate the dynamics of modifications during adaptation to stress

This approach can reveal regulatory mechanisms controlling SPBC1711.03 function in response to environmental challenges, providing insights into stress signaling pathways in fission yeast.

What are common challenges when using SPBC1711.03 antibody and how can they be addressed?

Researchers may encounter several technical challenges when working with SPBC1711.03 antibody:

• High background in Western blots:

  • Increase blocking time and concentration (5-10% milk/BSA)

  • Optimize antibody dilution (test range from 1:500-1:5000)

  • Increase washing steps (5×10 minutes with TBST)

  • Use alternative blocking agents (casein, commercial blockers)

• Weak or no signal detection:

  • Increase protein loading (up to 80μg per lane)

  • Reduce antibody dilution (start with 1:250)

  • Extend primary antibody incubation (overnight at 4°C)

  • Enhance detection using signal amplification systems

  • Verify protein extraction efficiency, especially for membrane-associated proteins

• Multiple bands or unexpected band sizes:

  • Verify protein degradation with protease inhibitors

  • Check for isoforms or post-translational modifications

  • Confirm specificity with knockout controls

  • Optimize gel percentage for better resolution

Systematic troubleshooting using these approaches can significantly improve experimental outcomes and data quality.

How can I assess and improve antibody developability for long-term research projects?

For extended research projects using SPBC1711.03 antibody, assess and enhance antibody performance:

• Stability assessment:

  • Monitor antibody performance over time using consistent positive controls

  • Track key parameters like binding affinity, specificity, and background

  • Implement regular validation protocols to detect performance drift

• Improving developability:

  • Evaluate biophysical properties that correlate with long-term stability

  • Consider purification quality and storage buffer optimization

  • Document batch-to-batch variation when receiving new antibody lots

• Validation framework:

  • Develop standardized protocols for routine antibody validation

  • Create reference samples for internal quality control

  • Document all optimization parameters for reproducibility

This strategic approach to antibody management ensures consistent performance throughout extended research timelines.

How might advanced antibody engineering techniques improve SPBC1711.03 antibody research tools?

Current advances in antibody engineering offer exciting possibilities for enhancing SPBC1711.03 research:

• Structure-based design approaches:

  • Computational de novo design of antibodies using RFdiffusion and related approaches could create higher-specificity tools targeting epitopes of interest

  • Fine-tuning of antibody properties through targeted mutations in complementarity-determining regions (CDRs)

  • Design of single-domain antibodies with enhanced stability and tissue penetration

• Affinity maturation:

  • Directed evolution techniques to improve binding affinity

  • CDR optimization based on structural prediction models

  • Selection of variants with reduced cross-reactivity

• Specialized modifications:

  • Development of non-fucosylated variants for enhanced functionality

  • Introduction of site-specific conjugation sites for reporter molecules

  • Creation of bispecific formats for co-detection of interacting partners

These advances could significantly expand the utility of SPBC1711.03 antibodies as research tools for investigating fission yeast biology.

How can SPBC1711.03 antibody research contribute to the broader understanding of conserved stress response mechanisms?

SPBC1711.03 research has potential implications for understanding evolutionary conserved stress response mechanisms:

• Comparative analysis:

  • Compare SPBC1711.03 protein regulation with homologs in other yeast species and higher eukaryotes

  • Assess conservation of stress response elements and signaling pathways

  • Identify shared regulatory mechanisms across evolutionary distance

• Integration with stress response networks:

  • Position SPBC1711.03 within the core environmental stress response (CESR) network

  • Investigate connections to stress-activated MAPK pathways (Sty1p, Atf1p)

  • Compare with analogous pathways in other model organisms

• Translational relevance:

  • Explore applications of findings to agricultural stress resistance

  • Investigate potential relevance to human disease models

  • Contribute antibody validation data to repositories like PLAbDab for broader research use

This broader perspective positions SPBC1711.03 research within the context of fundamental cellular biology and potential applications in understanding environmental adaptation mechanisms.